Keywords
Right to Health. Health Policy. Marketing of product. Sanitary Surveillance.
DOI:
https://doi.org/10.17566/ciads.v5i0.269How to Cite
1.
Analysis of judgments delivered by TJDFT on unregistered medicines. Cad. Ibero Am. Direito Sanit. [Internet]. 2016 Dec. 30 [cited 2025 Apr. 30];5:8-25. Available from: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/269
Abstract
This article is general theme analysis on the provision of medicines no national registry at TJDFT in the years 2013-2015. Has so systematized the arguments of decisions and their use of the foundations of the preliminary injunction suspension (STA) 175 the Supreme Court (STF) and the utterances of the National Council of Justice (CNJ) by either party to the process, from analytical description of qualiquantitativos data. It was found of respondent’s judgments, the grounds for the decision STA 175 and statements provided the basis for granting the medicine without national registry on behalf of the user, even without national evidence about their effectiveness and safety - which occurred in 62 % of the studied cases.
Authors and coauthors retain copyright but license the right of first publication to the Iberoamerican Journal of Health Law.
The Journal has been using CC Attribution 4.0 International (CC BY 4.0) since January 2023. This license allows the user to share and adapt the work, but they must give the appropriate credit to authors and coauthors and mention the Iberoamerican Journal of Health Law. The license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International was used until 2022.